This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany

Melindah Sharma
Co-Chair, Women’s Health Catalyst – Cardiovascular Health, Wyss Institute at Harvard University
Speaker

Profile

Melindah Sharma, Global Life Sciences Executive, Growth & Transformation | Harvard Wyss Institute | Aspen Institute | American Heart Association | Executive-in-Residence, HIP Fund | Rare Disease Mom

Melindah Sharma is a global life sciences executive with nearly three decades of experience leading strategy, commercialization, and enterprise transformation across more than 20 countries, including senior leadership roles at Johnson & Johnson and Manatt Health.

She serves as Co-Chair, Women’s Health Catalyst – Cardiovascular Health, at the Wyss Institute at Harvard University, is a Health Innovators Fellow with the Aspen Institute, and serves on the American Heart Association’s International Committee. She is also an Executive-in-Residence at the HIP Fund and Angel Investor.

A first-generation Indian-American, Melindah brings a global perspective and commercial rigor to advancing healthcare innovation, particularly in women’s health. She is passionate about connecting science, technology, capital, and human experience to expand access and improve patient outcomes worldwide.

Agenda Sessions

  • Women’s Health: Healthcare’s Largest Underserved Market and Biggest Growth Opportunity

    , 11:15